Yiqi Chutan Tang Reduces Gefitinib‐Induced Drug Resistance in Non‐Small‐Cell Lung Cancer by Targeting Apoptosis and Autophagy

High incidence and mortality rates for non‐small‐cell lung cancer (NSCLC) lead to low survival rates. Epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKI) are commonly first prescribed for NSCLC patients with EGFR mutations. However, most patients with sensitizing EGFR mutations be...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jue, Sun, Lingling, Cui, Jian, Wang, Jing, Liu, Xiaomin, Aung, Thazin Nwe, Qu, Zhipeng, Chen, Zhuangzhong, Adelson, David L., Lin, Lizhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004076/
https://www.ncbi.nlm.nih.gov/pubmed/31411813
http://dx.doi.org/10.1002/cyto.a.23869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004076/
https://www.ncbi.nlm.nih.gov/pubmed/31411813
http://dx.doi.org/10.1002/cyto.a.23869

Ejemplares similares